Grant Campany

Grant Campany is currently the CFO at NemaLife Inc. Prior to this, they served as the Interim CEO at Microdermics from January 2015 to December 2018. Grant was also the Entrepreneur-in-Residence (EIR) Fellow at the FDA from October 2012 to May 2013. From March 2010 to April 2020, Grant served as the Executive Director | Life Sciences at XPRIZE. Most recently, they were the Interim CEO at Renovar Bio, Inc. from December 2020 to June 2022. Grant has also held the position of Chief Business Officer at Yinuoke Biopharma from March 2018 to February 2021. Prior to that, they were a Life Science Strategist at B LOGiQ Consultancy from September 2007 to March 2010. Grant started their career as a Strategist, Portfolio Impact & Evaluation at the Gordon and Betty Moore Foundation from October 2003 to August 2007.

Grant Campany has earned a Master of Business Administration (MBA) from the University of Minnesota - Carlson School of Management with a focus in banking, corporate, finance, and securities law. Grant also holds a Bachelor of Science in Business (BSB) from the university's Carlson School of Management with a focus in biology and strategic marketing. Additionally, Grant has earned certification from LinkedIn in The Six Morning Habits of High Performers and Artificial Intelligence Foundations: Machine Learning.

Their manager is Siva Vanapalli, Co-Founder & CEO. Grant Campany works with Dhaval Patel - Director of Research & Innovation, Kellen Ketchersid - Director of Operations, and Mizanur Rahman - Co-Founder & CTO.